Drug Substance (CDMO/CRO)
Drug Product (CMO)

Find and compare companies providing Drug Product (CMO) services for:
Sterile injectables

HIGHLIGHTED

Located in:

Germany

Plants in:

Germany

Established in: 2008

Production scale:

large

small

medium

Employees: 4.000

With 14 production sites in Europe and the USA

7 Development Centers of Excellence covering all dosage forms

13 locations with Technology Services on site for seamless Tech Transfer and product Life-Cycle Management

  • GMP

  • FDA

  • EMA

All certificates

  • gmp

  • fda

  • ema

Replies quickly

HIGHLIGHTED

Located in:

United States

Plants in:

GermanyFranceGreeceSwitzerlandNorwayJapan

Production scale:

large

medium

small

Specialized in complex product development and manufacturing.

High-quality standards with a focus on customer-specific needs.

Agile and innovative approach to CDMO services.

  • GMP

  • FDA

  • EMA

All certificates

  • gmp

  • fda

  • ema

Replies quickly

HIGHLIGHTED

Located in:

India

Plants in:

India

Established in: 2023

Production scale:

small

medium

large

Employees: 1000+

Expertise in Conventional, Complex, and Niche Chemistries

End-to-end Support from early development to Commercial Phases

Comprehensive Analytical Support Facilities

  • GMP

  • FDA

  • EMA

All certificates

  • fda

  • ema

  • gmp

Replies quickly

Plants in:

AustriaGermany

Established in: 1934

Production scale:

large

small

medium

Employees: 1500

Full-Service CDMO with End-to-End Solutions

Reliable Global Distribution Operating in over 70 countries

Specialized in hormones, crystal-suspensions and complex injectables

  • GMP

  • FDA

  • EMA

All certificates

  • gmp

  • ema

Replies quickly

Plants in:

United StatesIndiaFranceGermanyUnited KingdomSpainItaly

Established in: 1991

Production scale:

small

medium

large

Employees: 3,500+

More than 12 GMP manufacturing facilities (EU, US, India)

Portfolio of more than 240 commercial APIs

We are experts in the cGMP production of highly potent compounds

  • GMP

  • FDA

  • EMA

All certificates

    Replies quickly

    Plants in:

    China

    Established in: 1987

    Production scale:

    medium

    small

    large

    Employees: 50+

    ISO 9001:2015 & SGS audited supplier

    One-stop CDMO Solutions for APl and Key intermediates

    Specialized in APIs & Pharmaceutical Intermediates for 38 years

    • GMP

    • FDA

    • EMA

    All certificates

    • gmp

    Replies quickly

    Plants in:

    United States

    Established in: 2016

    Production scale:

    medium

    small

    Low Volume high value API Fill and Finish Service

    In-line monitoring, SKAN Isolators, Highly Experienced Staff

    Capacity Available, Ready for your API

    • GMP

    • FDA

    • EMA

    All certificates

    • gmp

    Replies quickly

    Plants in:

    India

    Established in: 1989

    Production scale:

    large

    Employees: 5000+

    6 production facilities approved by USFDA, AGES-Austria, PMDA, WHO

    R&D Centers with capabilities of ANDAs, DMFs and NDDS

    462+ patents filed for drug substances and polymorphs

    • GMP

    • FDA

    • EMA

    All certificates

    • gmp

    • fda

    Replies quickly

    Plants in:

    China

    Established in: 2014

    Production scale:

    small

    medium

    large

    Employees: 1000+

    24 years of production experience

    6 workshops and 9 production lines which has 100t/month production capacity

    4 USDMFS & 8 CEPS & 200+ Patents

    • GMP

    • FDA

    • EMA

    All certificates

    • gmp

    Replies quickly

    Located in:

    China

    Plants in:

    China

    Established in: 2016

    Production scale:

    small

    medium

    large

    Employees: 200

    PFAS-Free Peptides

    Certified Quality & Sustainability with ISO 9000 certification and RSPO audited supplier & GMP

    Specialized in APIs & Pharmaceutical Intermediates

    • GMP

    • FDA

    • EMA

    All certificates

    • gmp

    Replies quickly

    Located in:

    Spain

    Plants in:

    Spain

    Established in: 1940

    Production scale:

    large

    Leading global provider of plasma-derived medicines.

    Strong focus on innovation in bioscience solutions.

    Comprehensive services from plasma collection to finished product.

    • GMP

    • FDA

    • EMA

    All certificates

      Replies slower than most

      Located in:

      Germany

      Plants in:

      Germany

      Established in: 1950

      Excellence in aseptic filling and packaging solutions for biologics.

      Customized solutions for pre-filled syringes, vials, and cartridges.

      Strong track record in supporting global market launches.

      • GMP

      • FDA

      • EMA

      All certificates

        Replies slower than most

        Plants in:

        United States

        Established in: 2018

        Production scale:

        large

        Successfully inspected by TGA, PMDA, MHRA, ANVISA, Health Canada, MPA, IMB, & FDA

        All facilities are in good standing with all regulatory authorities, including DEA, EPA, OSHA

        Quality Management System and supporting analytical processes are almost 100% electronic

        • GMP

        • FDA

        • EMA

        All certificates

        • gmp

        Replies quickly

        Located in:

        United States

        Plants in:

        United States

        Production scale:

        large

        Leading in aerosol and transdermal drug delivery systems.

        Expertise in both small molecule and biologic drug formulation.

        Strong track record in bringing complex therapies to market.

        • GMP

        • FDA

        • EMA

        All certificates

        • gmp

        Replies slower than most

        Looking for Drug Product (CMO) Services?

        Find a list of providers specializing in CMOs/CDMOs Services for Sterile injectables. Navigate through our extensive selection to identify the supplier that aligns with your specific needs.

        Pharmaoffer makes it easy and convenient to send inquiries at no cost. Directly connect with your chosen supplier and take the first step towards fulfilling your pharmaceutical needs easily and efficiently.

        Drug Product (CMO)

        Drug Product CMOs (contract pharmaceutical manufacturing) specialize in formulating, manufacturing, and packaging finished dosage forms such as tablets, capsules, injectables, and liquids. These organizations enable pharmaceutical companies to bring safe, effective, and compliant medicines to market by offering GMP-certified production capabilities, scalability, and regulatory support.

        Sterile injectables

        What is sterile injectables outsourcing (CMO)?

        Sterile injectables outsourcing is working with a Contract Manufacturing Organization to aseptically fill and finish injectable drug products, including vials, syringes, ampoules, and cartridges. Typical steps include compounding, sterile filtration, filling, stoppering, inspection, and secondary packaging.

        Key constraints include sterility assurance, container closure integrity, endotoxin control, and cold chain requirements. Sterile injectable CMOs also manage component sourcing and line changeover planning.

        When to choose a CMO for sterile injectables

        • You need aseptic or terminally sterilized fill finish capacity.
        • You require lyophilization or specialized container formats.
        • You need inspection systems and packaging aligned to target markets.

        Common buyer requirements

        • Container format, fill volume, and sterility approach defined.
        • Cold chain handling or temperature-controlled storage if needed.
        • Validated inspection and container closure integrity testing.

        Drug Product buyer guide (CMO)

        Use this guide to compare sterile injectable contract manufacturing services and avoid delays in aseptic processing.

        How to choose the right Contract Manufacturing Organization for sterile injectables
        • Line fit: vial, syringe, or cartridge compatibility with your fill volume.
        • Sterility assurance: media fill history and environmental monitoring performance.
        • Lyophilization: freeze-dryer capacity and cycle control if required.
        • Inspection: manual or automated systems and rejection handling.
        RFQ template: what to include for sterile injectables
        • Container format: vial, syringe, ampoule, or pen.
        • Fill volume: target volume and tolerances.
        • Sterility: aseptic processing or terminal sterilization.
        • Batch sizes: clinical and commercial demand.
        • Packaging: labeling, serialization, and device components.
        Common pitfalls in sterile injectables outsourcing
        • Component shortages: long lead times for stoppers and syringes.
        • Media fill delays: scheduling impacts launch timelines.
        • Compatibility gaps: container closure integrity issues if components are mismatched.
        Validation and regulatory notes for sterile injectables
        • Process validation: aseptic process simulations and line qualification.
        • Cleaning validation: critical for multi-product aseptic suites.
        • Regulatory alignment: inspection history for target markets.

        Sterile Injectables CMO services FAQ

        Practical answers for buyers searching for sterile fill finish CMOs and injectable drug product manufacturing.

        What does a sterile injectables CMO manufacture?

        Sterile injectables CMOs manufacture vials, prefilled syringes, ampoules, and cartridges. Services include aseptic fill finish, terminal sterilization, and packaging.

        What is sterile fill finish CMO support?

        Sterile fill finish involves filling drug product into sterile containers under aseptic conditions, followed by stoppering, capping, inspection, and packaging.

        Do sterile injectable CMOs offer lyophilization?

        Many do. Confirm lyophilizer size, cycle development support, and vial handling equipment if your product requires freeze-drying.

        What are common container formats for injectable drug product manufacturing?

        Common formats include vials, prefilled syringes, ampoules, and pens. Each format has specific component and inspection requirements.

        How do I evaluate aseptic processing capabilities?

        Review cleanroom classification, environmental monitoring, media fill history, and operator training. These indicators show sterility assurance performance.

        Can CMOs handle biologics in sterile injectable formats?

        Some CMOs handle biologic drug products with cold chain or low-temperature filling. Confirm material compatibility and temperature controls.

        What batch sizes are typical for sterile injectable CMOs?

        Batch sizes range from small clinical lots to large commercial runs. Provide your forecast to match line speed and vial size capabilities.

        What is the difference between aseptic fill finish and terminal sterilization?

        Aseptic fill finish maintains sterility throughout processing, while terminal sterilization sterilizes the sealed container after filling. Product sensitivity often determines the approach.

        Do sterile injectable CMOs provide pharmaceutical packaging services?

        Many CMOs provide secondary packaging, labeling, and serialization. Confirm compatibility with your device or combination product needs.

        What are common pitfalls in sterile injectables outsourcing?

        Common pitfalls include component shortages, media fill delays, and container closure integrity issues. Early planning helps align timelines.

        How do I compare pharmaceutical contract manufacturing organizations for sterile injectables?

        Compare sterility assurance history, container format capabilities, inspection systems, and regulatory track record. Use this directory to shortlist sterile fill finish CMOs.

        Is cold chain support common for injectable CMOs?

        Some CMOs provide cold chain handling and refrigerated storage, but not all. Clarify temperature ranges and monitoring expectations in your RFQ.

        What should I include in a sterile injectable RFQ?

        Include container format, fill volume, sterility approach, batch size, and packaging requirements. Provide stability data and target markets for regulatory alignment.

        Does finished dosage form manufacturing include injectable inspection?

        Yes. Visual inspection and container closure integrity testing are common parts of injectable drug product manufacturing.